Preclinical study of recombinant human bone morphogenetic protein-2: application of hyperbaric oxygenation during bone formation under unfavourable condition | Canada Hyperbarics Skip to main content
Study Int J Oral Maxillofac Surg 2003

Preclinical study of recombinant human bone morphogenetic protein-2: application of hyperbaric oxygenation during bone formation under unfavourable condition

Okubo Y, Bessho K, Fujimura K, Kusumoto K, Suzuki T, Segami N, et al. — Int J Oral Maxillofac Surg, 2003

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated how hyperbaric oxygen therapy (HBOT) at 2.0 atmospheres absolute for three weeks affected bone formation when combined with a bone-forming protein (rhBMP-2) in rats with reduced blood flow.

What They Found

Rats treated with HBOT showed a greater number of bone-building cells (osteoblasts) and a significantly larger area of new bone compared to untreated rats. They also had significantly higher levels of alkaline phosphatase activity and calcium content, indicating enhanced bone formation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

A key limitation is that this was a preclinical study conducted on rats, meaning the findings may not directly apply to human patients.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 12767880
Year Published 2003
Journal Int J Oral Maxillofac Surg
MeSH Terms Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Collagen Type I; Humans; Hyperbaric Oxygenation; Image Processing, Computer-Assisted; Implants, Experimental; Ischemia; Male; Muscle, Skeletal; Osteogenesis; Random Allocation; Rats; Rats, Wistar; Recombinant Proteins; Transforming Growth Factor beta

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.